Chemical modification of hamster arylamine N-acetyltransferase 2 with isozyme-selective and nonselective N-arylbromoacetamido reagents

Protein Journal

Volumn 23, Issue 2, 2004, Pages 153-166

  Wang, Haiqing ^a   Guo, Zhijun ^a   Vath, Gregory M ^a   Wagner, Carston R ^a   Hanna, Patrick E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

2 (acetylamino)fluorene; Acetanilide; Affinity labeling; Mass spectrometry (MS); N acetyltransferases; Tandem mass spectrometry (MS MS)

Indexed keywords

2 (BROMOACETYLAMINO)FLOURENE; ACETANILIDE DERIVATIVE; ACYLTRANSFERASE; AROMATIC AMINE; ARYLHYDROXYLAMINE; BROMOACETANILIDE; FLUORENE DERIVATIVE; HYDROXYLAMINE; ISOENZYME; N ACETYLTRANFERASE 2; N ACETYLTRANSFERASE 1; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; 2 (BROMOACETYLAMINO)FLUORENE; 2-(BROMOACETYLAMINO)FLUORENE; ARYLAMINE ACETYLTRANSFERASE; CYSTINE; DRUG DERIVATIVE; ENZYME INHIBITOR; N (2 FLUORENYL)ACETAMIDE; N-ACETYLTRANSFERASE 1; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ACETYLATION; AFFINITY LABELING; ALKYLATION; ARTICLE; BIOTRANSFORMATION; CHEMICAL MODIFICATION; CHEMICAL REACTION; ELECTROSPRAY; ENZYME ACTIVATION; HAMSTER; KINETICS; MASS SPECTROMETRY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; ENZYME SPECIFICITY; ISOLATION AND PURIFICATION; METABOLISM;

CRICETINAE;

2-ACETYLAMINOFLUORENE; ACETANILIDES; ACETYLATION; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; CRICETINAE; CYSTINE; ENZYME INHIBITORS; ISOENZYMES; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTRATE SPECIFICITY;

EID: 7444263434     PISSN: 15723887     EISSN: 18758355     Source Type: Journal    
DOI: 10.1023/B:JOPC.0000020082.14480.e2     Document Type: Article

References (22)

1. Andres, H. H., Klem, A. J., Schopfer, L. M., Harrison, J. K., and Weber, W. W. (1988). J. Biol. Chem. 263: 7521-7527.
2. Beland, F. A., and Kadlubar, F. F. (1990). Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. Handbook Exp. Pharmacol. 94/1: 267-325.
3. Bergstrom, C. P., Wagner, C. R., Ann, D. K., and Hanna, P. E. (1995). Protein Expr. Purif. 6: 45-55.
4. Bradford, M. M. (1976). Anal. Biochem. 72: 248-254.
5. Cheon, H. G., Boteju, L. W., and Hanna, P. E. (1992). Mol. Pharmacol. 42: 82-93.
6. Cheon, H. G., and Hanna, P. E. (1992). Biochem. Pharmacol. 43: 2255-2268.
7. Guo, Z., Vath, G. M., Wagner, C. R., and Hanna, P. E. (2003). J. Protein Chem. 22: 631-642.
8. Hanna, P. E. (1994). Adv. Pharmacol. 27: 401-430.
9. Hanna, P. E. (1996). Curr. Med. Chem. 3: 195-210.
10. Hein, D. W., Doll, M. A., Fretland, A. J., Gray, K., Deitz, A. C., Feng, Y., et al. (1997). Mutat. Res. 376: 101-106.
11. Kato, R., and Yamazoe, Y. (1995). Drug Metab. Rev. 27: 241-256.
12. Kitz, R., and Wilson, I. B. (1962). J. Biol. Chem. 237: 3245-3249.
13. Levy, G. N., and Weber, W. W. (2002). In Ionnides, c. (ed.), Enzyme Systems That Metabolize Drugs and Other Xenobiotics, John Wiley & Sons, New York, pp. 441-457.
14. Levy, H. M., Leber, P. D., and Ryan, E. M. (1963). J. Biol. Chem. 238: 3654-3659.
15. NIH Guidelines for the Laboratory Use of Chemical Carcinogens (1981). NIH Publication No. 81-2385, U.S. Government Printing Office, Washington, DC.
16. Payton, M., Mushtaq, A., Yu, T-W., Wu, L-J., Sinclair, J., and Sim, E. (2001). Microbiology 147: 1137-1147.
17. Sinclair, J. C., Sandy, J., Delgoda, R., Sim, E., and Noble, M. E. M. (2000). Nat. Struct. Biol. 7: 560-564.
18. Sticha, K. R. K., Sieg, C. A., Bergstrom, C. P., Hanna, P. E., and Wagner, C. R. (1997). Protein Expr. Purif. 10: 141-153.
19. Sticha, K. R. K., Bergstrom, C. P., Wagner, C. R., and Hanna, P. E. (1998). Biochem. Pharmacol. 56: 47-59.
20. Wagner, C. R., Bergstrom, C. P., Koning, K. R., and Hanna, P. E. (1996). Drug Metab. Disp. 24: 245-253.
21. Wick, M. J., Yeh, H-M., and Hanna, P. E. (1990). Biochem. Pharmacol. 40: 1389-1398.
22. Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J-M., Evens, D. A. P., Grant, D. M., et al. (1995). Pharmacogenetics, 5: 1-17.